NP / PA
Priority Medical Clinic, LLC
Priority Medical Clinic, LLC was paid $1.46M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoPRIORITY MEDICAL CLINIC, LLC
LAUREL, MS 39440
LAUREL, MS 39440
33aNPI1669805297assigned 08/19/2013
33bProvider typeFamily Nurse Practitioner
28Total paid$1.46M
24GClaims60,805
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Mississippi
Rank by total paid#4 of 206
Median peer was paid$22K
This provider vs. median67×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,318 | $208K | |
| 2019 | 7,902 | $171K | |
| 2020 | 7,195 | $185K | |
| 2021 | 9,996 | $276K | |
| 2022 | 12,192 | $303K | |
| 2023 | 6,597 | $198K | |
| 2024incomplete | 4,605 | $120K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 10,711 | 8,412 | $608K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 13,058 | 9,871 | $535K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.3% | 8,819 | 4,962 | $63K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 518 | 463 | $53K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.5% | 2,057 | 1,639 | $52K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 653 | 548 | $39K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 3,126 | 1,404 | $30K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 940 | 714 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,443 | 2,784 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 396 | 326 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 645 | 593 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,244 | 3,380 | $6K |
20 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 419 | $5K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 20 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,795 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,639 | $2K |
| 80305 | <1% | 209 | $2K | |
| 94690 | <1% | 51 | $1K | |
| 86328 | <1% | 47 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,351 | $1K |
| 94375 | <1% | 51 | $966.96 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 726 | $786.34 |
| 81003 | <1% | 532 | $744.52 | |
| 94200 | <1% | 51 | $543.39 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 110 | $471.93 |
| 90756 | <1% | 23 | $286.11 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $192.11 |
| 90715 | <1% | 54 | $169.58 | |
| J0945 | Injection, brompheniramine maleate, per 10 mg | <1% | 39 | $1.15 |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 1,072 | $0.26 |
| 99000 | 0% | 925 | $0.00 | |
| A4215 | Needle, sterile, any size, each | 0% | 1,068 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOCHRAN, LINDY (OWNER)